Journal
FRONTIERS IN NEURAL CIRCUITS
Volume 10, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fncir.2016.00064
Keywords
stem cell therapy; GABA; medial ganglionic eminence; excitation-inhibition; neuropsychiatric disorders
Categories
Funding
- New York State Office of Mental Health
- Public Health Service Award [P01 NS048120]
- Sidney R. Baer, Jr. Foundation
- Gray Matters at Columbia Psychiatry
Ask authors/readers for more resources
Due to the inadequacy of endogenous repair mechanisms diseases of the nervous system remain a major challenge to scientists and clinicians. Stem cell based therapy is an exciting and viable strategy that has been shown to ameliorate or even reverse symptoms of CNS dysfunction in preclinical animal models. Of particular importance has been the use of GABAergic interneuron progenitors as a therapeutic strategy. Born in the neurogenic niches of the ventral telencephalon, interneuron progenitors retain their unique capacity to disperse, integrate and induce plasticity in adult host circuitries following transplantation. Here we discuss the potential of interneuron based transplantation strategies as it relates to CNS disease therapeutics. We also discuss mechanisms underlying their therapeutic efficacy and some of the challenges that face the field.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available